Magritek has made benchtop NMR suitable for the rapid identification and quantitation of analytes during chemical reactions, in batch and continuous flow processes.

The new ABLE 3D Magnetic Stir and Disposable Bioreactor System from AMSBIO provides cost-effective, lab-scale production of induced pluripotent stem (iPS) cell spheroid culture.

Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity. Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform.

Offering combines Revvity’s market leading reagents with SCIEX precise innovative MS/MS for labs looking to expand newborn screening capabilities.

Expanded footprint, new capabilities mark IDT’s entrance into CRISPR therapeutics space.

Refeyn®, has unveiled its latest innovation, the MassFluidix® High Concentration (HC) microfluidic system, which extends the analytical strength of mass photometry to high-concentration protein samples.

At its Capital Markets Day in Visp (CH), Lonza shared a detailed update on its strategic priorities and provided new Mid-Term Guidance for 2024 to 2028.

Revvity, Inc. and Element Biosciences, Inc., a developer of the AVITI™ System, announced a collaboration to introduce workflow solutions that save time and effort required for genomic analysis of samples.

The Life Science Group Sartorius introduces the Picus® 2 Electronic Pipette, the latest addition to its portfolio of electronic pipettes. With a combination of advanced connectivity and excellent performance, Picus® 2 sets a new standard.

New free of charge service will offer insights in under ten days to sponsors conducting clinical trials in any indication, identifying potential “zombie trials” and providing actionable recommendations for failing trials.